tumor stage
tumor grade
lymphovascular invasion
lymph node spread
A. tumor stage
the anterior urethra drains into the inguinal and pelvic nodes
the posterior urethra drains into the pelvic nodes
the proximal two-thirds drain into the external and internal iliac nodes
the distal one-third drains into the obturator nodes
tumor stage
tumor grade
lymphovascular invasion
lymph node spread
history of pulmonary TB
total incontinence
immunosuppression
impaired renal function
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
mid prostate to the verumontanum at the 5 and 7 oclock positions
lateral margins of the prostate at the 10 and 2 oclock positions
entire area distal to the urethral crest
area between ejaculatory duct openings and prostatic utricle
leiomyoma
hemangioma
fibroepithelial polyp
lymphangioma
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
comparable
nodular or sessile lesions usually invade muscle
papillary bladder tumors are typical of low stage and grade
carcinoma in situ appears as a flat, velvety patch
sarcomas commonly invade bladder base and ureteral orifices causing obstructions
2%
5%
70%
90%
well-differentiated tumor with broad-based invasive font
marked atypia distributed on wide areas of superficial urothelium
atypia is present
no atypia but marked degenerative epithelial changes
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
transitional cell carcinoma
squamous cell carcinoma
adenocarcinoma
small cell carcinoma
cisplatin
BCG
mitomycin C
5-fluorouracil
only in females
associated with chronic irritation, polypoid cystitis, and cystitis glandularis
no risk for squamous cell carcinoma
treated with estrogen, if symptomatic
40 - 55%
55 - 70%
70 - 85%
85 - 100%
frequently found in association with high-grade or extensive TCC
has a rate of progression to muscle invasion of 10-25%
significant areas of CIS are easily missed by routine cystoscopy
treatment begins with TURBT
immediately before operation
immediately before incision and post-operative for 1 day
immediately before incision and post-operative for 15 days
immediately before incision and post-operative for 30 days
RB
cyclin A
HRAS
CD-44
ascending urethrography
voiding cystourethrography
MRI
IVU
working with organic chemicals and dyes
abuse of pain-control medications especially phenacetin
exposure to arsenic and aromatic amines
schistosomiasis
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
high specificity
high sensitivity
high reliability
strong validity
irritative bladder symptoms
obstructive bladder symptoms
palpable suprapubic mass on physical examination
painless profuse hematuria
upper ureter
middle ureter
lower ureter
comparable
never
unlikely
likely
always
the standard treatment is transurethral resection
the prognosis for inverted papilloma is pathetic, with a recurrence rate of approximately 65%
the likelihood of synchronous urothelial carcinoma is 26%
has been shown to harbor p53 gene mutations
often of high-grade sarcomas
often associated with muscularis propria invasion
due to vesical polyps occluding ureteric orifices
should be resected but not diathermized
obstructive LUTS are common presentations and occur in association with carcinoma in situ
might present as perineal abscesses and fistulae
could be asymptomatic
venereal diseases increase the risk of urethral cancers
leiomyosarcoma
rhabdosarcoma
carcinosarcoma
neurosarcoma
obesity
consuming artificial sweeteners
asbestosis
analgesic abuse